Smirking Shkreli refuses lawmakers' questions, calls them 'imbeciles'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/24/2026
- S&P 500 ends marginally lower as investors focus on US-Iran war
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oil gains on little sign of progress in US-Iran talks
- S&P 500 history shows strong gains across Fed hiking cycles: BCA
- JPMorgan upgrades CoreWeave on stronger compute pricing
- Plug Power COO resigns to join another company
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- Akamai signs $11.6B deal with Anthropic, up to $20B potential
Valeant Pharma (VRX) IMS Script Data Remains Strong in Week 2 Post-Walgreens - Evercore ISI
February 5, 2016 8:12 AM ESTEvercore ISI analyst Umer Raffat highlighted week two data from Valeant Pharma (NYSE: VRX) post the Walgreens deal, which showed continued healthy trends. Scripts are up 50% from pre-Walgreens levels.
The analyst highlighted the following:
This graph is NOT suggesting these... More
